https://journals.sagepub.com/doi/10.1177/02611929241263184      

       

PROSILICO will attend the following conferences and present new results      

ANDROMEDA 2.0 will be launched on Feb 15th. Welcome to attend our release event in…

     

PROSILICO is happy to announce a strategic partnership with Phenaros Pharmaceuticals (https://www.phenaros.com/). Together, we will…

PROSILICO will attend and present at Biotech Hanse in Stockholm and RSC Anglo-Nordic Medicinal Chemistry…

PROSILICO attended IDDST in Tokyo 8-10 May and gave an oral presentation of new ANDROMEDA…

In 49 study comparisons, ANDROMEDA by Prosilico outperformed laboratory methods in 74 % of cases…

PROSILICO participates in the planned SciLifeLab PULSE cofund postdoctoral programme SciLifeLab has the ambition to…